Zobrazeno 1 - 10
of 201
pro vyhledávání: '"ERIKA, TÓTH"'
Autor:
Erika Tóth, Zsófia Kürönya, Edina Soós, Tamás Pintér, Henriett Butz, Zsolt Horváth, Erzsébet Csernák, Vince Kornél Grolmusz, Judit Székely, Tamás Straussz, József Lövey, Levenete Jánvári, László Báthory-Fülöp, Péter Nagy, Csaba Polgár, Attila Patócs
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Recent developments in molecular genetic testing methods (e.g. next-generation sequencing [NGS]-panels) largely accelerated the process of finding the most appropriate targeted therapeutic intervention for cancer patients based on molecularly targeta
Externí odkaz:
https://doaj.org/article/2378294547c842d0a17ba88dade9265b
Autor:
Botond Bukovszky, János Fodor, Gábor Székely, Erika Tóth, Tibor Major, Ferenc Oberna, Zoltán Takácsi-Nagy, Csaba Polgár
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1598-1605 (2023)
Most of the neck node metastases from cancer of unknown primary (CUP) are squamous cell carcinomas (SCCs). The majority of which are human papillomavirus (HPV)-related, frequently show cystic morphology referring to Waldeyer’s ring origin. Here, we
Externí odkaz:
https://doaj.org/article/33afdbaf375a4a8fb5bb268aac9ce1a1
Autor:
Mónika Révész, Ferenc Oberna, András Slezák, Erika Tóth, Örs Ferenczi, István Kenessey, Zoltán Takácsi-Nagy
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5250 (2024)
EZH2 (Enhancer of zeste homolog 2) promotes tumor growth and survival through numerous mechanisms and is a promising target for novel therapeutic approaches. We aimed to characterize the expression of EZH2 in the tumors of young head-and-neck squamou
Externí odkaz:
https://doaj.org/article/312c96876a084fbdb6bcb5fb321b41e2
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 67, Iss 2, Pp 256-261 (2023)
ABSTRACT Objective: The aim of this study was to investigate how polarized sodium iodide symporter (NIS) expression may regulate iodide metabolism in vivo. Materials and methods: Polarized NIS expression was analyzed in tissues that accumulate iodide
Externí odkaz:
https://doaj.org/article/5261d479daf34f30aaad51da50f9065f
Autor:
Nedson T. Kashaija, Viktória Gável, Krett Gergely, Kovago Akos, Miklós Kürthy, Csaba Szabó, Erika Tóth, Zsuzsanna Szabó-Krausz
Publikováno v:
Journal of Composites Science, Vol 8, Iss 2, p 60 (2024)
Wastewater treatment plants (WWTPs) are critical infrastructures for wastewater management, and their durability is crucial. Due to their excellent water tightness and strength, cementitious materials are used to build WWTPs. However, the performance
Externí odkaz:
https://doaj.org/article/55ed917eac2d496e87d8a8d46dcc66b7
Autor:
Bence Bátai, Ákos Nagy, Laura Kiss, Stefánia Gróf, Péter Attila Király, Ádám Jóna, Judit Demeter, Hermina Santa, Arpad Batai, Piroska Pettendi, Tamás Szendrei, Márk Béla Plander, Gábor Kőrösmezey, Hussain Alizadeh, Béla Kajtár, Gábor Méhes, László Krenács, Botond Timár, Judit Csomor, Erika Tóth, Tamás Schneider, Gabor Mikala, András Matolcsy, Donat Alpar, András Masszi, Csaba Bödör
Publikováno v:
HemaSphere, Vol 7, p e303289c (2023)
Externí odkaz:
https://doaj.org/article/fe1f54764a91430ab1d604497e34a641
Autor:
Zsófia Küronya, Tímea Danyi, Tímea Balatoni, Gabriella Liszkay, Erika Tóth, Krisztina Biró, Lajos Géczi
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-6 (2022)
Abstract Background The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma. We present the case of a patient with
Externí odkaz:
https://doaj.org/article/90db1b9897ba443a8fa308ec90124416
Autor:
László Krenács, Dóra Krenács, Zita Borbényi, Erika Tóth, Anna Nagy, Klára Piukovics, Enikő Bagdi
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 428 (2023)
Peripheral T-cell lymphomas (PTCLs) expressing multiple follicular T helper (TFH) cell-related antigens are now classified as TFH lymphomas (TFHL), including angioimmunoblastic, follicular, and not otherwise specified (NOS) types. CXCR5 is the TFH ce
Externí odkaz:
https://doaj.org/article/f4c1eb6af0554c93898075ec0d8fc63d
Autor:
Bernadett, Lévay, Alexandra, Kiss, Georgina, Fröhlich, Erika, Tóth, András, Slezák, Ilona, Péter, Ferenc, Oberna, Orsolya, Dohán
Publikováno v:
Diagnostics (2075-4418); Sep2024, Vol. 14 Issue 17, p1858, 8p
Autor:
Eszter Bencze, Krisztina Bogos, Andrea Kohánka, László Báthory-Fülöp, Veronika Sárosi, Erzsébet Csernák, Nóra Bittner, Zsombor Melegh, Erika Tóth
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
EGFR mutation in non-small cell lung cancer (NSCLC) offers a potential therapeutic target for tyrosine kinase inhibitor (TKI) therapy. The majority of these cases, however eventually develop therapy resistance, mainly by acquiring EGFR T790M mutation
Externí odkaz:
https://doaj.org/article/791ae1e67c614efcaf1a1b0756e5936c